Nongonococcal urethritis treatment in men with avelox (moxifloxacin)

Aboian, I.A.; Pavlov, S.V.; Miroshnichenko, V.I.; Shestel', A.N.

Urologiia 2007(1): 49-52

2007


ISSN/ISBN: 1728-2985
PMID: 17472000
Document Number: 612266
The role of urogenical infection in males in present-day urology is demonstrated with a focus on fluoroquinolones efficacy in combined treatment of urogenital infection. The mechanism of action, pharmacokinetics, the spectrum of antimicrobial activity of a novel fluoroquinolone drug avelox are detailed. Avelox use in combined therapy of mono- and mixed infections caused by ureaplasmas, chlamidias, mycoplasms is illustrated by original experience of the authors. Avelox is well tolerated and safe.

Document emailed within 1 workday
Secure & encrypted payments